The Dermatology Digest

AUGUST 13, 2024

FDA The approval is based on positive results from the phase III OLYMPIA clinical trials – the largest clinical trial program conducted in this condition to date – in which nemolizumab demonstrated significant and clinically meaningful improvements in itch and skin nodules at Week 16, with rapid reductions in itch observed as early as Week 4.

Dermatitis 36

Dermatitis Safety Clinic Dermatology 36

The Dermatology Digest

JULY 10, 2024

Almirall expects regulatory decisions for lebrikizumab in moderate-to-severe AD in additional European markets, including the United Kingdom and Switzerland in 2024. The letter stated no concerns about the clinical data package, safety, or label for lebrikizumab. Eli Lilly and Company recently announced that the U.S.

Dermatitis 36

Dermatitis Safety Dermatology Marketing 36

NIMA Institute

JUNE 30, 2023

Safety and Ethical Practices: Nima places a strong emphasis on safety and ethical practices in Botox and filler administration. Nima’s commitment to safety ensures that you are equipped with the knowledge and skills to prioritize the well-being of your patients and deliver optimal outcomes.

Training 52

Training Medical Esthetics Ethics Esthetics 52

The Dermatology Digest

FEBRUARY 13, 2024

MediWound Ltd’s EscharEx bested market leader collagenase Santyl ointment in wound debridement, promotion of granulation tissue, and time to wound closure in patients with chronic venous leg ulcers (VLU). The safety profile and overall incidence of adverse wound reactions were comparable between arms. days for EscharEx vs. 76.0

Safety 36

Safety Marketing Office Clinic 36

The Dermatology Digest

JANUARY 4, 2024

The BLA submission for DMB-3115 is based on results from phase III multi-regional clinical trials in patients with plaque psoriasis, in which the primary endpoint was the rate of change in the Psoriasis Area and Severity Index (PASI) for skin symptoms. market during the next five years. commercialization.

Pharmaceutical 36

Pharmaceutical Partnerships Clinic Safety 36

The Dermatology Digest

MARCH 11, 2024

In addition, results from the phase III ARCADIA clinical trials in atopic dermatitis (AD) found that nemolizumab-treated patients who responded at 16 weeks maintained skin and itch responses through to week 48, even when dosing was reduced from every four to every eight weeks. No new safety signals were observed in this trial.

Dermatitis 36

Dermatitis Safety Dermatology Eczema 36

The Dermatology Digest

FEBRUARY 8, 2024

Jashin Wu, MD, founder and CEO of the Dermatology Research and Education Foundation in San Diego, CA, says that more psoriasis patients will see improvements in their condition due to the influx of new agents and biosimilars on the market. It has great efficacy and safety and is oral… [This means] no shot and no risk of anaphylaxis.”

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

DECEMBER 15, 2023

The approval is based on data from the Phase 3 ECZTRA 6 trial, which evaluated the efficacy and safety of Adbry in 289 pediatric patients aged 12-17 years with moderate-to-severe AD who were candidates for systemic therapy. Adbry, which is marketed outside of the U.S. She is the international coordinating investigator for ECZTRA 6.

Eczema 36

Eczema Dermatitis Safety Therapy 36

The Dermatology Digest

DECEMBER 15, 2023

The approval is based on data from the Phase 3 ECZTRA 6 trial, which evaluated the efficacy and safety of Adbry in 289 pediatric patients aged 12-17 years with moderate-to-severe AD who were candidates for systemic therapy. Adbry, which is marketed outside of the U.S. She is the international coordinating investigator for ECZTRA 6.

Eczema 36

Eczema Dermatitis Safety Therapy 36

The Dermatology Digest

DECEMBER 20, 2023

Mr. Raducha-Grace recently served as Head of Clinical Partnerships at Harbor Health. Before Harbor Health, he led product and go-to-market functions for CVS’s kidney care and home business units. Secondary measures of efficacy, as well as safety and pharmacokinetics, will also be assessed. Billingsley, MD.,

Dermatology 36

Dermatology Surgery Eczema Office 36

AAAMS

MAY 9, 2024

These programs usually combine theoretical knowledge with hands-on clinical experience to ensure that nurses are skilled in delivering safe and effective aesthetic treatments. Nurses were first taught the importance of maintaining a clean and sterile environment, with safety being the top priority.

Training 52

Training Ethics Technology Injections 52

The Dermatology Digest

DECEMBER 15, 2023

The approval is based on data from the Phase 3 ECZTRA 6 trial, which evaluated the efficacy and safety of Adbry in 289 pediatric patients aged 12-17 years with moderate-to-severe AD who were candidates for systemic therapy. Adbry, which is marketed outside of the U.S. She is the international coordinating investigator for ECZTRA 6.

Eczema 28

Eczema Dermatitis Safety Therapy 28

Aesthetics Advisor

AUGUST 18, 2023

and the Springfield Wellness Center that uses IV NAD+ as a clinical therapy. Overall, the clinical research and large volume of anecdotal evidence would suggest that NAD+ IV therapy can treat alcohol and drug addiction and Parkinson’s disease. Therefore, the frequency of dosing will vary from clinic to clinic but is usually irregular.

Therapy 36

Therapy Injections Safety Clinic 36

AAAMS

DECEMBER 9, 2022

the world’s premier corporate consulting firm and the definitive source for all things business, recently devoted an in-depth article to the rapid growth of the global aesthetic medicine market size. Explore current and upcoming aesthetic medicine trends, common procedures and more to learn how you can capitalize on this thriving market.

Chemical Peels 52

Chemical Peels Injections Marketing Networking 52

Southeastern Esthetics Institute

AUGUST 23, 2016

Having a thorough understanding of the dermatology and plastic surgery procedures, in addition to all new and modern cosmetic procedures on the market, is critical in assisting your clients in answering questions. Having daily and weekly communication when dealing with patients receiving treatment is critical.

Esthetician 195

Esthetician Esthetics Document Office 195

Aesthetics Advisor

NOVEMBER 7, 2023

The drug has been used successfully to grow new teeth in mice and ferrets, with clinical trials expected to begin in humans in July 2024 to test the drug’s safety in healthy adults. Dr. Takahashi said that he and his team hope to bring the drug to market by 2030. Reposted from: [link]

Clinic 36

Clinic Hospital Injections Surgery 36

New Age Spa Institute

JUNE 8, 2023

INGLOT is not exclusively marketed as a “clean beauty” brand, but Inglot Cosmetics emphasizes certain aspects of clean beauty in its formulations and practices. INGLOT places importance on ingredient safety, ethical practices and sustainability. They also offer a wide selection of vegan and cruelty-free cosmetic options.

Makeup 52

Makeup Training Esthetics Social Media 52

The Dermatology Digest

APRIL 23, 2021

DAXI will get an approval, most likely, for the longest acting toxin that we’ve had on the market.” In anticipation of this longer lasting duration, other brands are clinically testing higher doses for safety, efficacy, and patient satisfaction.

Injections 36

Injections Safety Clinic Branding 36

Aesthetic Advancements Institute (AAI)

JUNE 20, 2023

There is a new dermal filler on the market! Juvéderm’s® newest filler, Volux , has been approved by the FDA and is set to hit medical offices in early 2023. This new filler is designed to specifically target the jawline, an area of concern for many consumers seeking facial sculpting and contouring.

Training 36

Training Injections Medical Facials 36

The Dermatology Digest

AUGUST 30, 2023

I think the most clinically meaningful endpoint is the time to loss of none or mild.” According to Dr. Lain, the “median six-month duration” often is a return to baseline, not time to mild or moderate wrinkling, which may not be as clinically meaningful. “So But maybe it just takes some time for that to mature in the market.”

Wrinkles 36

Wrinkles Office Safety Clinic 36

Aesthetics Advisor

AUGUST 16, 2024

The number of chemicals restricted by the FDA is even more ridiculous when you consider there are over 84,000 different chemicals in use in your personal care products and only 1% of those have been evaluated for safety in humans. (1) Samples were taken from 315 men who presented at a fertility clinic with reproductive challenges.

Safety 36

Safety Ingredients Legal Facials 36

Kind of Stephen

APRIL 7, 2022

In a clinical trial ³ , the combination was shown to reduce acne faster and more effectively than each one alone. There are differences between formulas available on the market, so a flat-out rule of “never mix” is likely false. Why might someone want to use tretinoin and benzoyl peroxide together? on KindofStephen.

Pharmaceutical 40

Pharmaceutical Clinic Ingredients Safety 40

Aesthetics Advisor

AUGUST 6, 2023

Nicotinamide riboside's side effects NR is uniquely safe— it's been evaluated in 13 published human trials without any severe attributable side effects reported in clinical trials. Amongst them, Niagen® is the only patented form that has gone through the regulatory procedures to assess safety in key markets around the world.

Rosacea 36

Rosacea Dermatitis Safety Diet 36

Aesthetics Advisor

JULY 25, 2024

Let's start with safety first. Although this is a relatively old case (2002), it is a good safety reminder on the potential danger of slimming products like slimming pills. It might not be easy for you to differentiate which product is based on science and which is based on pure marketing hype. In 2015, the U.S.

Diet 36

Diet Extractions Sustainability Ingredients 36

New Age Spa Institute

JUNE 13, 2024

Established in 1992, the NCBTMB aims to enhance the credibility, safety, and professionalism of the massage therapy and bodywork industry through rigorous standards and continuing education. This accreditation enhances the credibility of our program and provides our students with a competitive edge in the job market.

Continuing Education 52

Continuing Education Continuous Education Education Esthetics 52

Aesthetics Advisor

FEBRUARY 20, 2024

Hydrolyzed collagen stands out as the most favored and promising skin nutraceutical for oral supplementation thanks to its superior absorption and encouraging outcomes in clinical trials compared to other collagen supplements. to 10 grams, he explains. billion by 2030, up from $696 million in 2021.

Collagen 36

Collagen Diet Marketing Vitamin C 36

Aesthetics Advisor

AUGUST 17, 2023

They're trying to take market share, now that DentSupply and Envista have left, but … we're trying to stop their exports to Asia with our Asian team. Unscrupulous “dentists” found that they could market this cheap mercury product as silver – and thereby compete with the better-trained dentists who preferred gold.

Safety 36

Safety Sales Marketing Training 36

Aesthetics Advisor

AUGUST 25, 2023

Large studies have shown that approximately one-third of MRI studies are performed using contrast because of the additional, clinically relevant information provided by the contrast administration.” Food and Drug Administration (FDA) issued a safety warning on Dec. On the regulatory front, the U.S. MRI machines per million residents.

Injections 36

Injections Medical Safety Tools 36

Aesthetics Advisor

MARCH 10, 2024

A Cleveland Clinic survey revealed that 50% of Americans use at least one type of technology to track their health, with most experiencing significant related physical and mental improvements. Americans are increasingly taking control of their health via the use of health monitoring technologies, with notable benefits as a result.

Technology 36

Technology Management Medical Tools 36

The Dermatology Digest

JULY 24, 2024

The two companies will collaborate in sales, marketing, education, and research. market share within three years. market,” says Ethan Min, CEO of BENEV, in a news release. .” market,” says Ethan Min, CEO of BENEV, in a news release. “We Hugel Inc.’s s botulinum toxin product Letybo is coming to the U.S.

Dermatology 78

Dermatology Sales Marketing Safety 78

The Dermatology Digest

APRIL 23, 2024

The CRL did not identify any deficiencies related to the clinical efficacy or clinical safety data in the BLA, and the FDA did not request any new clinical trials or clinical data to support the approval of pz-cel.

Marketing 36

Marketing Safety Clinic Sustainability 36

Aesthetics Advisor

FEBRUARY 13, 2024

Once reserved for the world's pro athletes and billionaires, the global Stem Cell Therapy market size was exhibited at USD 12.9 This important clinical trial demonstrated safety of the FMD and efficacy in reducing key biomarkers (risk factors) involved in aging, metabolic health , and chronic disease.

Diet 36

Diet Vitamin C Extractions Therapy 36

Aesthetics Advisor

JUNE 18, 2024

"The eyelids are very vascular, and the eyelid skin is very thin; this will make them more apparent under the eyelid skin and cause the appearance of dark circles," Miss Elizabeth Hawkes, consultant ophthalmic and oculoplastic surgeon at London's Cadogan Clinic, told POPSUGAR.

Vitamin C 36

Vitamin C Extractions Hydration Makeup 36

Aesthetics Advisor

JANUARY 3, 2024

The study, published in The American Journal of Clinical Nutrition (Oct 2021), used data from a long-term study group, the Framingham Offspring Cohort, which has been monitoring residents of this Massachusetts town, in the United States, since 1971. This preclinical research has taken curcumin from the lab to the clinic.

Collagen 36

Collagen Clinic Diet Medical 36

Aesthetics Advisor

APRIL 30, 2024

In fact, most “fish oils” on the market today are actually synthetic ethyl esters, which are different from the triglyceride and phospholipid forms omega-3 found in sea foods, which are roughly 50/50 triglycerides and phospholipids. It's not a silver bullet, but it's one thing you CAN do something about cheaply, safely, easily, quickly.

Safety 36

Safety Pharmaceutical Diet Marketing 36

Aesthetics Advisor

JANUARY 18, 2024

1 Since then, Korean and Chinese researchers have compiled extensive in vitro, animal, and clinical data on the safety and potential applications of lumbrokinase over the past 30 years. This built-in "balancing" mechanism may have contributed to the excellent safety record of lumbrokinase as explained later in the article.

Pharmaceutical 36

Pharmaceutical Extractions Clinic Safety 36

The Beauty Brains

FEBRUARY 25, 2019

Drug actives require a lot more safety and efficacy data than cosmetic ingredients. That means for the companies who want to sell the ingredients more expensive and lengthy clinical testing. The reason they are not approved is because the FDA looks at sunscreens as drugs while in the EU sunscreens are considered cosmetics.

Social Media 52

Social Media Legal Ingredients Safety 52